Reported October 31: Abbott Laboratories And Reckitt Benckiser Win First Trial In Premature-Infant Formula Litigation, Cleared Of Allegations Of Hiding Bowel Disease Risks
Reported October 31: Abbott Laboratories And Reckitt Benckiser Win First Trial In Premature-Infant Formula Litigation, Cleared Of Allegations Of Hiding Bowel Disease Risks
10月31日報道：雅培和利潔時贏得早產兒配方糾紛案的首次審判，被指控隱瞞腸道疾病風險的指控不成立。
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy. It was the companies' first trial win in litigation over the products.
雅培實驗室和Reckitt Benckiser集團的一家子公司被陪審團裁定免除指控，稱他們隱瞞了早產嬰兒配方奶粉可能導致腸道疾病，嚴重使一個嬰兒生病。這是公司在有關產品訴訟中的首次勝訴。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間